Adequanin vet. 250 mg/ml injeksjonsvæske, oppløsning
Adequanin vet. 250 mg/ml injeksjonsvæske, oppløsning
Authorised
- GLYCOSAMINOGLYCAN POLYSULFATE
Product identification
Medicine name:
Adequanin vet. 250 mg/ml injeksjonsvæske, oppløsning
Active substance:
- GLYCOSAMINOGLYCAN POLYSULFATE
Target species:
-
Horse
Route of administration:
-
Intraarticular use
Product details
Active substance and strength:
-
GLYCOSAMINOGLYCAN POLYSULFATE250.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intraarticular use
-
Horse
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AX12
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Norway
Package description:
- Available only in Norwegian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Daiichi Sankyo Altkirch
Marketing authorisation date:
Manufacturing sites for batch release:
- Vericore Limited
Responsible authority:
- NOMA
Authorisation number:
- 8149
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 23/03/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 1/03/2023
